Beta
Teriflunomide
medication Under reviewAn immunomodulatory medication used to treat relapsing forms of multiple sclerosis by reducing inflammation.
Research summary
Scientific evidence from multiple randomized controlled trials demonstrates teriflunomide's efficacy in reducing clinical relapses, MRI lesion activity, and disease progression in relapsing-remitting multiple sclerosis patients. Pooled safety data confirm a consistent profile with common manageable side effects like elevated liver enzymes, diarrhea, and hair thinning. No studies were identified involving healthy human subjects, limiting direct applicability to general wellness or supplementation in unaffected individuals.
Reported Side Effects
No reports yet
Be the first to report this effect and help the community.
Add Teriflunomide to your stack to report effects
Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial
Pooled Safety and Tolerability Data From Four Placebo-Controlled Studies of Teriflunomide in Patients With Relapsing-Remitting Multiple Sclerosis
No reports yet
Be the first to report this effect and help the community.
Add Teriflunomide to your stack to report effects
Pooled Safety and Tolerability Data From Four Placebo-Controlled Studies of Teriflunomide in Patients With Relapsing-Remitting Multiple Sclerosis
No reports yet
Be the first to report this effect and help the community.
Add Teriflunomide to your stack to report effects
Pooled Safety and Tolerability Data From Four Placebo-Controlled Studies of Teriflunomide in Patients With Relapsing-Remitting Multiple Sclerosis
No reports yet
Be the first to report this effect and help the community.
Add Teriflunomide to your stack to report effects
Pooled Safety and Tolerability Data From Four Placebo-Controlled Studies of Teriflunomide in Patients With Relapsing-Remitting Multiple Sclerosis
No reports yet
Be the first to report this effect and help the community.
Add Teriflunomide to your stack to report effects
Pooled Safety and Tolerability Data From Four Placebo-Controlled Studies of Teriflunomide in Patients With Relapsing-Remitting Multiple Sclerosis
Research (2 studies)
Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial
Pooled Safety and Tolerability Data From Four Placebo-Controlled Studies of Teriflunomide in Patients With Relapsing-Remitting Multiple Sclerosis
Community updates
No updates yet for this supplement.
Be the first to share your experience!